Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H24N4O3.ClH |
Molecular Weight | 392.88 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NC1=C(NC\C=C/COC2=NC=CC(CN3CCCCC3)=C2)C(=O)C1=O
InChI
InChIKey=ODBOENMSSFCACZ-PVOKDAACSA-N
InChI=1S/C19H24N4O3.ClH/c20-16-17(19(25)18(16)24)22-7-2-5-11-26-15-12-14(6-8-21-15)13-23-9-3-1-4-10-23;/h2,5-6,8,12,22H,1,3-4,7,9-11,13,20H2;1H/b5-2-;
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C19H24N4O3 |
Molecular Weight | 356.4189 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/1971169Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/9730007
Sources: http://www.ncbi.nlm.nih.gov/pubmed/1971169
Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/9730007
Pibutidine hydrochloride (IT-066), a novel histamine H2 receptor antagonist has powerful and long lasting antisecretory and antiulcer effects and is a useful antisecretory drug for treatment of peptic ulcer diseases.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1941 Sources: http://www.ncbi.nlm.nih.gov/pubmed/10028383 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration. | 1990 Jan |
|
Effect of pibutidine hydrochloride on nitric oxide production in rat gastric mucosa. | 1998 Jun |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/11130203
oral administration of a 20-mg dose of pibutidine hydrochloride
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/10028383
When H2-receptor transfected cells were treated with IT-066 (PIBUTIDINE) for 30 min, the inhibitory effect of IT-066 on the [3H]tiotidine binding still remained even after the cells were extensively washed. Scatchard plot analysis supported the non-competitive and irreversible action of IT-066. When the canine mutated H2-receptor-expressed cells were used, which have substituted amino acid of 190Alanine (Ala; position: 190th amino acid) for 190Threonine (Thr) in the fifth transmembrane domain, IT-066 also inhibited [3H]tiotidine binding to the cells concentration-dependently.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 07:32:39 GMT 2023
by
admin
on
Sat Dec 16 07:32:39 GMT 2023
|
Record UNII |
IF88DF5F6V
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
32000
Created by
admin on Sat Dec 16 07:32:39 GMT 2023 , Edited by admin on Sat Dec 16 07:32:39 GMT 2023
|
PRIMARY | |||
|
126463-66-9
Created by
admin on Sat Dec 16 07:32:39 GMT 2023 , Edited by admin on Sat Dec 16 07:32:39 GMT 2023
|
PRIMARY | |||
|
5282449
Created by
admin on Sat Dec 16 07:32:39 GMT 2023 , Edited by admin on Sat Dec 16 07:32:39 GMT 2023
|
PRIMARY | |||
|
IF88DF5F6V
Created by
admin on Sat Dec 16 07:32:39 GMT 2023 , Edited by admin on Sat Dec 16 07:32:39 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |